Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT01590095 |
| Other study ID # |
PR-11063 |
| Secondary ID |
2011-09-3652 (UC |
| Status |
Active, not recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
May 2012 |
| Est. completion date |
December 2022 |
Study information
| Verified date |
January 2022 |
| Source |
International Centre for Diarrhoeal Disease Research, Bangladesh |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
Brief Summary:
The purpose of this study is to measure the independent and combined effects of interventions
that improve water quality, sanitation, hand washing, and nutrition on child growth and
development in the first years of life.
Description:
Detailed Description:
Infection and inadequate diet are proximate risk factors for under-nutrition and early life
growth faltering; the two processes likely act reciprocally in a vicious cycle that
perpetuates physiologic and metabolic deficits and increases the risk of mortality. Children
who exhibit growth faltering are more likely to have deficits in cognitive development and
long-term human capital, and are more likely to have children who also suffer from growth
deficits - perpetuating the cycle into the next generation.
There are two probable interdependent pathways that link enteric infections to child growth
and development. The first pathway includes repeated infections the lead to acute illness or
parasitic infection in the first years of life, which increase the risk of stunting and
subsequent cognitive deficits in childhood and later in life. The second pathway is through a
subclinical condition called environmental enteropathy (EE).
There is limited evidence to demonstrate whether or not water quality, sanitation, and hand
washing (WASH) interventions can improve measures of EE, child growth and development, and
whether nutritional interventions could be enhanced if provided concurrently with WASH
interventions. To help fill this evidence gap, the WASH Benefits study will deliver
randomized interventions designed to reduce infection and improve nutrition, and will measure
intervention effects on child illness, growth and development. WASH Benefits includes two,
comparable but standalone trials in Bangladesh and Kenya that are registered under separate
protocols.
In Bangladesh, the study will include 720 clusters, and each cluster will enroll 8 household
compounds (baris) with pregnant women in their second or third trimester. The study will
randomize 90 clusters to each of 6 active intervention arms (water quality, sanitation, hand
washing, combined WSH, nutrition, nutrition+WSH), and 180 clusters to a standard practices
non-intervention arm. Children born into the cohort will be followed for 2 years after the
intervention, with measurements at 12 and 24 months after intervention delivery. (anticipated
age range: 20 - 27 months old at the final measurement). At the 12- and 24-month follow-up
visits, the study will collect child anthropometric measurements and caregiver-reported
diarrhea. In the final visit the study will administer a test to measure child development
outcomes. The study will collect urine, blood, and stool specimens from a subsample of 1,500
children distributed across four arms of the study (Control, combined WSH, Nutrition,
Nutrition+WSH) to measure biomarkers of gut function and intestinal parasitic infections at
the 12- and 24-month follow-up visits. In addition, the study will collect specimens (blood,
stool) from children 18 - 27 months old at baseline who are living in the same compound as
target children to test for intestinal parasitic infections. At 24-months in all arms, the
study will collect specimens stool from target children, children 18 - 27 months old at
baseline, a school-aged child, and an adult who are living in the same compound as target
children to test for intestinal parasitic infections. At 36-months in all arms, the study
will collect specimens stool from target children, a school-aged child, and an adult who are
living in the same compound as target children to test for intestinal parasitic infections.